tirzepatide obstructive sleep apnea fda approval 2024 New approved indication for Zepbound Eli Lilly's weight loss drug
Description
This means it not only helps in reducing body weight but also plays a significant role in controlling blood sugar levels
15 It has been proven that the combined effect of alcohol and metabolic dysfunction negatively affects patient prognosis and requires combined therapeutic interventions
Providers not registered with the board: The provider must be registered with their regulatory board
Key takeaways include: Tirzepatide led to clinically meaningful improvements in AHI and patient-reported sleep quality
